Search
Now showing items 1-10 of 22
Treatment of hepatitis C virus infection in patients of northern India
(2004)
BACKGROUND AND AIM: The purpose of the present study was to evaluate the therapeutic response of north Indian patients with chronic hepatitis C (CH-C) to two different treatment regimens of interferon and ribavirin. METHODS: ...
Hepatitis G virus in India.
(1996)
Genotype determination of hepatitis C virus from northern India: identification of a new subtype.J Med Virol.
(1996)
Hepatitis C virus (HCV) shows substantial nucleotide sequence diversity distributed throughout the viral genome, with many variants showing only 68-79% overall sequence homology. This has led to problems in diagnosis of ...
The epidemiologic significance and clinical pattern of HCV induced chronic hepatitis in India.
(1994)
Hepatitis C virus (HCV) ribonucleic acid (RNA) was tested for in a group of 16 defined non-B chronic hepatitis patients using specific reverse transcription polymerase chain reaction (RT-PCR). These were chosen from amongst ...
Etiological role of hepatitis E virus in sporadic fulminant hepatitis
(1994)
Non-A, non-B hepatitis viruses have been implicated as the etiological agent(s) in up to 60% of patients with fulminant hepatitis. These agents are reported to induce a higher mortality than other causes of fulminant ...
Diagnosis of hepatitis C virus-associated chronic liver disease in India: comparison of HCV antibody assay with a polymerase chain reaction for the 5' noncoding region.
(1994)
The relative value of an anti-hepatitis C virus (HCV) serological assay and reverse transcriptase-nested polymerase chain reaction assays (RT-PCR) were investigated for the constant 5' putative noncoding region of HCV for ...
Chronic hepatitis in a large Indian hospital.
(1993)
BACKGROUND. In developed countries as well as in Southeast Asia, the hepatitis B and C viruses are the main causes of chronic hepatitis. In India, however, there have been no major investigations on the aetiology of chronic ...
Immune response to hepatitis B virus surface antigen peptides during HBV infection.
(1992)
Antibody responses of patients with acute (n = 73), fulminant (n = 30) and chronic (n = 51) hepatitis B virus (HBV) infection as well as recovered individuals (n = 7) were studied against three synthetic peptides, Pre-S1 ...
Vitamin E-based therapy is effective in ameliorating transaminasemia in nonalcoholic fatty liver disease
(2005)
BACKGROUND: Comparative trials of ursodeoxycholic acid (UDCA), vitamin E and weight management programs among patients with nonalcoholic fatty liver disease (NAFLD) are lacking. AIM: To find an effective single agent or ...
Vaccination for hepatitis A virus is not required for patients with chronic liver disease in India
(2002)
BACKGROUND: Hepatitis A virus (HAV) vaccination is recommended worldwide for patients with chronic liver disease to prevent decompensation due to superinfection with HAV. India being endemic for HAV, the prevalence of ...